Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adenosine A 2A receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function
Alfredo Oliveros, Ki Hyun Yoo, Mohammad Abdur Rashid, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 28
Open Access | Times Cited: 21

Showing 21 citing articles:

Persisting blood–brain barrier disruption following cisplatin treatment in a mouse model of chemotherapy-associated cognitive impairment
Roland Patai, Boglarka Csik, Ádám Nyúl‐Tóth, et al.
GeroScience (2025)
Open Access | Times Cited: 2
Cisplatin and methotrexate induce brain microvascular endothelial and microglial senescence in mouse models of chemotherapy-associated cognitive impairment
Boglarka Csik, Kiana Vali Kordestan, Rafał Gulej, et al.
GeroScience (2025)
Open Access | Times Cited: 1
Striatopallidal adenosine A2A receptor modulation of goal-directed behavior: Homeostatic control with cognitive flexibility
Jiang‐Fan Chen, Doo‐Sup Choi, Rodrigo A. Cunha
Neuropharmacology (2023) Vol. 226, pp. 109421-109421
Open Access | Times Cited: 19
Pharmacology of Adenosine Receptors: Recent Advancements
Fabrizio Vincenzi, Silvia Pasquini, Chiara Contri, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1387-1387
Open Access | Times Cited: 16
Sensorineural hearing loss and cognitive impairment: three hypotheses
He Zhao, Yan Wang, Limei Cui, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 6
Nanotechnology Approaches for Prevention and Treatment of Chemotherapy‐Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors
Sarah Nevins, Callan D. McLoughlin, Alfredo Oliveros, et al.
Small (2023)
Open Access | Times Cited: 15
Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved
Simona Serini, Gabriella Calviello
Antioxidants (2024) Vol. 13, Iss. 4, pp. 486-486
Open Access | Times Cited: 4
The biological intersection between chemotherapy-related cognitive impairment and Alzheimer’s disease
Matthew Torre, Camila A. Zanella, Mel Β. Feany
American Journal Of Pathology (2025)
Open Access
Downregulation of the glucose transporter GLUT 1 in the cerebral microvasculature contributes to postoperative neurocognitive disorders in aged mice
Ying Chen, Jin Joo, John Man-Tak Chu, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Blockade of adenosine A2A receptors reverses early spatial memory defects in the APP/PS1 mouse model of Alzheimer’s disease by promoting synaptic plasticity of adult-born granule cells
Ji Qi, Yang Yang, Yun Xiong, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
The impact of purine nucleosides on neuroplasticity in the adult brain
Beatriz dos Santos, Tetsade Piermartiri, Carla I. Tasca
Purinergic Signalling (2024)
Closed Access | Times Cited: 2
Adenosine and adenosine receptors in metabolic imbalance-related neurological issues
Mi‐Hyeon Jang, Juhyun Song
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116996-116996
Open Access | Times Cited: 1
The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function
Mohammad Abdur Rashid, Jason J. Tang, Ki-Hyun Yoo, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 3
The neuroprotective effects of Piracetam on cisplatin-induced cognitive decline
Maha ELBeltagy, Bann Khraisat, Lujain AlZoubi, et al.
International Journal of Neuroscience (2023), pp. 1-8
Open Access | Times Cited: 3
Diagnostic and Treatment Approaches to Chemo Brain
Fatma Gül Helvacı Çelik, Meltem Puşuroğlu, Sefanur Köse, et al.
Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry (2024) Vol. 17, Iss. 2, pp. 301-322
Open Access
A2A receptor signaling drives cisplatin-mediated hippocampal neurotoxicity and cognitive defects in mice
Benjamin B. Gyau, Silvia Deaglio
Purinergic Signalling (2023) Vol. 19, Iss. 4, pp. 591-593
Open Access | Times Cited: 1
Cardioprotective effect of oleuropein in a cisplatin-induced cardiotoxicity model in rats
İshak Gökçek
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 3403-3410
Closed Access | Times Cited: 1
A Novel Therapy for Cisplatin-Induced Allodynia and Dysfunctional and Emotional Impairments in Male and Female Mice
Ignacio Martínez-Martel, Olga Pol
Antioxidants (2023) Vol. 12, Iss. 12, pp. 2063-2063
Open Access | Times Cited: 1
Aberrant adenosine signaling in patients with focal cortical dysplasia
Mengyi Guo, Jing Zhang, Jing Wang, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Downregulation of the Glucose transporter GLUT 1 in the cerebral microvasculature contributes to postoperative neurocognitive disorders in aged mice
Ying Chen, Jin Joo, John Man-Tak Chu, et al.
Research Square (Research Square) (2023)
Open Access
Chemobrain: An accelerated aging process linking adenosine A2A receptor signaling in cancer survivors
Alfredo Oliveros, Michael Poleschuk, Peter D. Cole, et al.
International review of neurobiology (2023), pp. 267-305
Open Access
Page 1

Scroll to top